Drugs and Somatic Motor Activity Flashcards
Identify the neurotransmitter released by somatic neurons at the neuromuscular junction
Acetylcholine is released
It binds to specific receptors on the muscle fibre membrane (sarcolemma), triggering a cascade of events that lead to muscle contraction
Identify the receptor type expressed at the somatic neuromuscular junction:
Nicotinic acetylcholine receptors (nAChRs) are expressed at the neuromuscular junction
These ligand-gated ion channels (Nm subtype) open upon ACh binding, allowing Na⁺ influx and muscle depolarisation
Known as Nm (muscle-type nicotinic receptor)
Explain why nicotinic agonists act as muscle relaxants and give an example of this type of drug:
Nicotinic agonists overstimulate nAChRs, causing persistent depolarisation.
This leads to depolarisation blockade, preventing further muscle contraction.
Example: suxamethonium – used for temporary paralysis during intubation or surgery
Explain why nicotinic antagonists also act as muscle relaxants and give an example of this type of drug:
Nicotinic antagonists block ACh from binding to nAChRs,
Prevent depolarisation of the muscle fibre membrane, which means the muscle cannot contract.
The antagonists effectively paralyse the muscle, making them muscle relaxants
antagonists block the receptor from being activated
As a result, nicotinic antagonists such as tubocurarine and pancuronium prevent Ach mediated muscle contraction
Explain the rationale behind the use of anticholinesterase drugs as an adjunct to surgery
Drugs which inhibit cholinesterase enzyme and reduce acetylcholine breakdown
Reversible anticholinesterases bind to the enzyme and are hydrolysed by it, but at a very slow rate compared to Ach
Clinical benefits:
- speeds up recovery as patient regains muscle function more quickly
- prevents respiratory complications
Describe the role of neuromuscular blocking agents during surgery:
During surgery, neuromuscular blocking agents (NMBAs) are used to induce muscle relaxation
Depolarising blockers:
- suxamethonium
- initially produce a prolonged depolarisation, followed by relaxation
Non-depolarising blockers:
- pancuronium
- Competitively block nicotinic receptors at the neuromuscular junction (NMJ), preventing acetylcholine (Ach) from activating skeletal muscles
What are the 3 possible channel states ?
Resting, open, and inactivate